ZykadiaCyramzaFruzaqlaFruquintinibImfinzidurvalumabramucirumabBrigatinibceritinib
…), atezolizumab (Tecentriq), osimertinib (Tagrisso), ceritinib (Zykadia) and nintedanib (Vargatef). EMA labels for all products include…
7articles mentioning drugs
15drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Palbociclib ×
Palbociclib
This drug is selected. Its supporting articles are shown below.
Articles mentioning Palbociclib
7 articles · page 1 of 1palbociclibretifanlimabMemorial Sloan Kettering Cancer Centerdedifferentiated liposarcomaDDLPS
…emic therapy prior to surgery, were eligible. Patients received palbociclib (125 mg orally, days 1–21 of a 28-day cycle) plus retifanlimab …
ribociclibPalbociclibletrozoleRibociclib-inducedCDK4/6Ihuman epidermal growth factor receptor 2-negative metastatic breast cancerendocrine therapy
…tatic HR+ breast cancer in her 60s was prescribed letrozole and ribociclib. She developed acute diarrhea, and a surveillance CT demonstrat…
palbociclibribociclibabemaciclibCurcuma longacurcuminbreast cancerLee et al
…ent kinase 4/6 inhibitors (CDK4/6i)—abemaciclib, ribociclib and palbociclib—have transformed the treatment of hormone receptor-positive, HE…
abemaciclibribociclibpalbociclibWithania somniferaAshwagandhahormone receptor-positive, HER2-negative metastatic breast cancer
…4/6 inhibitors (CDK4/6i), including palbociclib, ribociclib and abemaciclib, has transformed the prognosis of hormone receptor-positive, HE…
inavolisibpalbociclibfulvestrantpalbociclib-fulvestrantpomalidomideadjuvant endocrine therapybreast cancer
…eting adjuvant endocrine therapy.In the pivotal INAVO120 trial, inavolisib demonstrated a benefit over palbociclib-fulvestrant, with a med…
abemaciclibribociclibpalbociclibfulvestrantanastrozoleletrozolebreast cancerRegional University Hospital of Málagaendocrine therapy
…have doubled progression-free survival. Approved agents include abemaciclib, palbociclib, and ribociclib. In the MONARCH 2 trial, abemacicl…